1 U.S. lawmaker has disclosed 1 Ionis Pharmaceuticals, Inc. trade under the STOCK Act — 0 buys and 1 sell in 2016. Congress has been net sellers of IONS.
*Notional-weighted price return on lawmakers' disclosed buys of IONS, marked to the latest close — per-share (share counts aren't disclosed).
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2016-01-20 | Sheldon Whitehouse | SELL | $1K–$15K | $42.83 | $80.69 2026-06-29 | -88.4% exit |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
1 member of the U.S. House and Senate has disclosed Ionis Pharmaceuticals, Inc. transactions under the STOCK Act — 0 purchases and 1 sale. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
Every IONS trade is marked to the latest close in the Return column; sells matched to a prior buy show a realized round-trip return.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded IONS and how it performed.